Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children

European Journal of Endocrinology

Volumn 159, Issue 6, 2008, Pages 791-797

  Shaikh, M Guftar ^a   Grundy, Richard G ^a   Kirk, Jeremy M W ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; RESISTIN;

ADIPOGENESIS; ADOLESCENT; ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CANCER; CHILD; CONTROLLED STUDY; FEMALE; HORMONE RESISTANCE; HUMAN; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPOPITUITARISM; HYPOTHALAMIC OBESITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT GAIN; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; HYPERINSULINISM; HYPOTHALAMUS; HYPOTHALAMUS DISEASE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; HYPERINSULINISM; HYPOPITUITARISM; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; LEPTIN; MALE; OBESITY;

EID: 58149343864     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0533     Document Type: Article

References (54)

1. Lee M & Korner J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary, 2008. In Press, DOI:10.1007/s1102-008-0096-4.
2. Bray GA & Gallagher TF Jr. Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine 1975 54 301-330.
3. Inoue S & Bray GA. An autonomic hypothesis for hypothalamic obesity. Life Sciences 1979 25 561-566.
4. Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M & Brauner R. Hormonal factors influencing weight and growth pattern in craniopharyngioma. Hormone Research 2000 53 163-169.
5. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S & Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebocontrolled trial. Journal of Clinical Endocrinology and Metabolism 2003 88 2586-2592.
6. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL & Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 1999 135 162-168.
7. Bray GA, Inoue S & Nishizawa Y. Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus. Diabetologia 1981 20 (Supplement) 366-377.
8. King BM & Frohman LA. The role of vagally-medicated hyperinsulinemia in hypothalamic obesity. Neuroscience and Biobehavioral Reviews 1982 6 205-214.
9. Ahima RS. Central actions of adipocyte hormones. Trends in Endocrinology and Metabolism 2005 16 307-313.
10. Schwartz MW. Brain pathways controlling food intake and body weight. Experimental Biology and Medicine 2001 226 978-981.
11. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG. Central nervous system control of food intake. Nature 2000 404 661-671.
12. Jequier E. Leptin signaling, adiposity, and energy balance. Annals of the New York Academy of Sciences 2002 967 379-388.
13. Steppan CM & Lazar MA. Resistin and obesity-associated insulin resistance. Trends in Endocrinology and Metabolism 2002 13 18-23.
14. Chandran M, Phillips SA, Ciaratdi T & Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003 26 2442-2450.
15. Soodini GR. Adiponectin and leptin in relation to insulin sensitivity. Metabolic Syndrome and Related Disorders 2004 2 114-123.
16. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001 409 307-312.
17. Steppan CM & Lazar MA. The current biology of resistin. Journal of Internal Medicine 2004 255 439-447.
18. Chehab FF. Obesity and lipodystrophy - where do the circles intersect? Endocrinology 2008 149 925-934.
19. Conneely KN, Silander K, Scott LJ, Mohlke KL, Lazaridis KN, Valle TT, Tuomilehto J, Bergman RN, Watanabe RM, Buchanan TA, Collins FS & Boehnke M. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 2004 47 1782-1788.
20. Lee JH, Chan IL, Yiannakouris N, Kontogianni M, Estrada E, Scip R, Orlova C & Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 4848-4856.
21. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PWF & Meigs JB. Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 3165-3172.
22. Ahima RS & Lazar MA. Adipokines and the peripheral and neural control of energy balance. Molecular Endocrinology 2008 22 1023-1031.
23. Cole T, Bellizzi MC, Flegal KM & Dietz W. Establishing a standard definition for childhood overweight and obesity worldwide: international survey. BMJ 2000 320 1240-1243.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
25. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S & Bazzarre T. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002 106 143-160.
26. Matthews DR, Hosker JF, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
27. Keskin M, Kurtoglu S, Kendirci M, Atabek ME & Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005 115 e500-e503.
28. de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG & Stanhope R. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. Journal of Clinical Endocrinology and Metabolism 1996 81 2734-2737.
29. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatrica Scandinavica 1988 77 587-592.
30. Stahnke N, Grubel G, Lagenstein I & Willig RP. Long-term follow-up of children with craniopharyngioma. European Journal of Pediatrics 1984 142 179-185.
31. Daousi C, Dunn AJ, Foy PM, MacFarlane IA & Pinkney JH. Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. American Journal of Medicine 2005 118 45-50.
32. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL & Kan LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 1999 135 162-168.
33. Brabant G, Horn R, Mayr B, von zur MA, Honegger J & Buchfelder M. Serum leptin levels following hypothalamic surgery. Hormone and Metabolic Research 1996 28 728-731.
34. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Frontiers in Neuroendocrinology 2003 24 225-253.
35. Banks WA, Kastin AJ, Huang W, Jaspan JB & Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996 17 305-311.
36. Munzberg H & Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience 2005 8 566-570.
37. Roth C, Wilken B, Hanefeld F, Schroter W & Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. European Journal of Endocrinology 1998 138 89-91.
38. Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, Kibirige MS, Price DA, Shalet SM, Wales JK, Ross RJ & Clayton PE. Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction. Journal of Pediatric Endocrinology and Metabolism 2002 15 963-971.
39. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW & Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2004 89 81-86.
40. Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA & Christensen ML. Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. Journal of Pediatrics 2006 148 23-29.
41. King BM, Phelps GR & Frohman LA. Hypothalamic obesity in female rats in absence of vagally mediated hyperinsulinemia. American Journal of Physiology 1980 239 E437-E441.
42. King BM. Ventromedial hypothalamic obesity: a reexamination of the irritative hypothesis. Neuroscience and Biobehavioral Reviews 1991 15 341-347.
43. King BM, Banta AR, Tharel GN, Bruce BK & Frohman LA. Hypothalamic hyperinsulinemia and obesity: role of adrenal glucocorticoids. American Journal of Physiology 1983 245 E194-E199.
44. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D & Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 2000 289 2122-2125.
45. Obici S, Feng Z, Karkanias G, Baskin DG & Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neuroscience 2002 5 566-572.
46. Niswender KD, Baskin DG & Schwartz MW. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends in Endocrinology and Metabolism 2004 15 362-369.
47. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C & Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. Journal of Clinical Investigation 1993 92 1824-1830.
48. Keskin M, Kurtoglu S, Kendirci M, Atabek ME & Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005 115 e500-e503.
49. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
50. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW & Meigs JB. Associations of adiponectin, resistin, and TNFα with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 3165-3172.
51. Steppan CM & Lazar MA. The current biology of resistin. Journal of Internal Medicine 2004 255 439-447.
52. Tovar S, Nogueiras R, Tung LYC, Castaneda TR, Vazquez MJ, Morris A, Williams LM, Dickson SL & Dieguez C. Central administration of resistin promotes short-term satiety in rats. European Journal of Endocrinology 2005 153 R1-R5.
53. Wilkinson M, Wilkinson D, Wiesner G, Morash B & Ur E. Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone. Neuroendocrinology 2005 81 19-30.
54. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE & Ahima RS. Adiponectin acts in the brain to decrease body weight. Nature Medicine 2004 10 524-529.